224 related articles for article (PubMed ID: 36384097)
1. Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.
Uceda-Castro R; Margarido AS; Cornet L; Vegna S; Hahn K; Song JY; Putavet DA; van Geldorp M; Çitirikkaya CH; de Keizer PLJ; Ter Beek LC; Borst GR; Akkari L; van Tellingen O; Broekman MLD; Vennin C; van Rheenen J
Cell Rep Med; 2022 Nov; 3(11):100821. PubMed ID: 36384097
[TBL] [Abstract][Full Text] [Related]
2. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Schlam I; Gatti-Mays ME
Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
[TBL] [Abstract][Full Text] [Related]
4. Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.
Duchnowska R; Pęksa R; Radecka B; Mandat T; Trojanowski T; Jarosz B; Czartoryska-Arłukowicz B; Olszewski WP; Och W; Kalinka-Warzocha E; Kozłowski W; Kowalczyk A; Loi S; Biernat W; Jassem J;
Breast Cancer Res; 2016 Apr; 18(1):43. PubMed ID: 27117582
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.
Morikawa A; Li J; Ulintz P; Cheng X; Apfel A; Robinson D; Hopkins A; Kumar-Sinha C; Wu YM; Serhan H; Verbal K; Thomas D; Hayes DF; Chinnaiyan AM; Baladandayuthapani V; Heth J; Soellner MB; Merajver SD; Merrill N
Cancer Res Commun; 2023 Jun; 3(6):1093-1103. PubMed ID: 37377606
[TBL] [Abstract][Full Text] [Related]
6. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases.
Carney CP; Pandey N; Kapur A; Woodworth GF; Winkles JA; Kim AJ
Drug Deliv Transl Res; 2021 Dec; 11(6):2344-2370. PubMed ID: 34716900
[TBL] [Abstract][Full Text] [Related]
7. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
[TBL] [Abstract][Full Text] [Related]
8. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
9. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.
Wang S; Liang K; Hu Q; Li P; Song J; Yang Y; Yao J; Mangala LS; Li C; Yang W; Park PK; Hawke DH; Zhou J; Zhou Y; Xia W; Hung MC; Marks JR; Gallick GE; Lopez-Berestein G; Flores ER; Sood AK; Huang S; Yu D; Yang L; Lin C
J Clin Invest; 2017 Dec; 127(12):4498-4515. PubMed ID: 29130936
[TBL] [Abstract][Full Text] [Related]
10. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Shah N; Mohammad AS; Saralkar P; Sprowls SA; Vickers SD; John D; Tallman RM; Lucke-Wold BP; Jarrell KE; Pinti M; Nolan RL; Lockman PR
Pharmacol Res; 2018 Jun; 132():47-68. PubMed ID: 29604436
[TBL] [Abstract][Full Text] [Related]
11. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
[TBL] [Abstract][Full Text] [Related]
12. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
13. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L
J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
An M; Zang X; Wang J; Kang J; Tan X; Fu B
Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
[TBL] [Abstract][Full Text] [Related]
15. Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis.
Evans KT; Blake K; Longworth A; Coburn MA; Insua-Rodríguez J; McMullen TP; Nguyen QH; Ma D; Lev T; Hernandez GA; Oganyan AK; Orujyan D; Edwards RA; Pridans C; Green KN; Villalta SA; Blurton-Jones M; Lawson DA
Nat Cell Biol; 2023 Dec; 25(12):1848-1859. PubMed ID: 37957324
[TBL] [Abstract][Full Text] [Related]
16. Management of brain metastases in breast cancer: a review of current practices and emerging treatments.
Mills MN; Figura NB; Arrington JA; Yu HM; Etame AB; Vogelbaum MA; Soliman H; Czerniecki BJ; Forsyth PA; Han HS; Ahmed KA
Breast Cancer Res Treat; 2020 Apr; 180(2):279-300. PubMed ID: 32030570
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
[TBL] [Abstract][Full Text] [Related]
18. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
19. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study.
Morikawa A; Peereboom DM; Thorsheim HR; Samala R; Balyan R; Murphy CG; Lockman PR; Simmons A; Weil RJ; Tabar V; Steeg PS; Smith QR; Seidman AD
Neuro Oncol; 2015 Feb; 17(2):289-95. PubMed ID: 25015089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
